Radiation therapy for stage IIA/IIB seminomas: Back to the future?

IF 4.9 1区医学 Q1 ONCOLOGY

Radiotherapy and Oncology Pub Date : 2024-11-16 DOI:10.1016/j.radonc.2024.110626

Jennifer Le Guévelou, Luca Nicosia, Pierre Blanchard, Flavien Ralite, Xavier Durand, Vincent Marchesi, Guilhem Roubaud, Paul Sargos

引用次数: 0

Abstract

Seminoma is a highly curable disease; therefore, long-term morbidity of oncological treatment represents a crucial stake. In view of the considerable advances made in radiotherapy in the past decade, we aim to shed light on current and future strategies that hold promises for the management of stage II seminoma.

查看原文本刊更多论文

IIA/IIB 期精原细胞瘤的放射治疗：回到未来？

精原细胞瘤是一种高度可治愈的疾病；因此，肿瘤治疗的长期发病率关系重大。鉴于放射治疗在过去十年中取得了长足的进步，我们旨在阐明目前和未来有望治疗 II 期精索瘤的策略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Radiotherapy and Oncology 医学-核医学

CiteScore

10.30

自引率

10.50%

发文量

2445

审稿时长

45 days

期刊介绍： Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, translational studies, epidemiological outcomes, imaging, dosimetry, and radiation therapy planning, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as data science in radiation oncology and physics aspects relevant to oncology.Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published.